Global Thymidine Market Worth $ 191 Million by 2019

Date: 2016-09-19

Thymidine is a pyrimidine deoxynucleoside. In cell biology it is used to synchronize the cells in S phase. Thymidine includes anticancer and anti-HIV on the base of classification, which represent 36% and 34% of global thymidine market. 

Pharmaceuticals is the main application of thymidine product and Asia is the largest thymidine market on production and consumption.

Global thymidine market is projected to reach $ 191 Million by 2019, with a GAGR of 5.7% from 2015, and Asia will have a big dynamic momentum on the market growth. The major players in the global thymidine market are NHU Co, Starlake, Desano, MATRIX, Cobenpharm etc..


Read Full Report:

Joanna | Executive – International Business and partner Relations
E-mail: | Tel: 510-400-8520

Contact With Us
Join templatemonster at google+
Customized Research
Request Sample